Cargando…

SCOPE 2021: a new scorecard for osteoporosis in Europe

SUMMARY: This scorecard summarises key indicators of the burden of osteoporosis and its management in the 27 member states of the European Union, as well as the UK and Switzerland. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe. INT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanis, John A., Norton, Nicholas, Harvey, Nicholas C., Jacobson, Trolle, Johansson, Helena, Lorentzon, Mattias, McCloskey, Eugene V., Willers, Carl, Borgström, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172408/ https://www.ncbi.nlm.nih.gov/pubmed/34080059 http://dx.doi.org/10.1007/s11657-020-00871-9

Ejemplares similares

Osteoporosis in Europe: a compendium of country-specific reports
por: Willers, Carl, et al.
Publicado: (2022)

SCOPE: a scorecard for osteoporosis in Europe
por: Kanis, J. A., et al.
Publicado: (2013)

Fragility fractures in Europe: burden, management and opportunities
por: Borgström, Fredrik, et al.
Publicado: (2020)

FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine
por: Povoroznyuk, Vladyslav, et al.
Publicado: (2021)

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk
por: Dimai, Hans P., et al.
Publicado: (2022)

Potential Adverse Effect of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate
por: Zheng, Zhangan, et al.
Publicado: (2022)

Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism
por: Axelsson, Kristian F., et al.
Publicado: (2022)

Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density
por: Jaiswal, Raju, et al.
Publicado: (2023)

Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment
por: Ye, Carrie, et al.
Publicado: (2023)

Intervention thresholds and diagnostic thresholds in the management of osteoporosis
por: Kanis, John A., et al.
Publicado: (2022)

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
por: Lorentzon, Mattias, et al.
Publicado: (2022)

Temporal changes in access to FRAX® in Thailand between 2010 and 2018
por: Chotiyarnwong, Pojchong, et al.
Publicado: (2019)

Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study
por: McCloskey, E. V., et al.
Publicado: (2021)

Incidence of hip fracture in Saudi Arabia and the development of a FRAX model
por: Saleh, Yousef A. L., et al.
Publicado: (2022)

Epidemiology of hip fracture in Qatar and development of a country specific FRAX model
por: Abdulla, Nabeel, et al.
Publicado: (2022)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2012)

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
por: McCloskey, E. V., et al.
Publicado: (2020)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

A surrogate FRAX model for the Kyrgyz Republic
por: Lesnyak, O., et al.
Publicado: (2020)

A scorecard for osteoporosis in Canada and seven Canadian provinces
por: Kendler, D.L., et al.
Publicado: (2020)

Use of age-dependent FRAX-based intervention thresholds for Singapore
por: Kanis, John A., et al.
Publicado: (2020)

Extensive undertreatment of osteoporosis in older Swedish women
por: Lorentzon, M., et al.
Publicado: (2019)

The balanced scorecard: translating strategy into action
por: Kaplan, Robert S, et al.
Publicado: (1996)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
por: Söreskog, E., et al.
Publicado: (2021)

FRAX-based fracture probabilities in South Africa
por: Johansson, Helena, et al.
Publicado: (2021)

Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
por: Johansson, L., et al.
Publicado: (2022)

Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model
por: Kirilova, E., et al.
Publicado: (2020)

Reassessment Intervals for Transition From Low to High Fracture Risk Among Adults Older Than 50 Years
por: Leslie, William D., et al.
Publicado: (2020)

The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density
por: Larsson, B. A. M., et al.
Publicado: (2020)

One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD
por: Larsson, B.A.M., et al.
Publicado: (2021)

UK clinical guideline for the prevention and treatment of osteoporosis
por: Gregson, Celia L., et al.
Publicado: (2022)

Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI)
por: Harvey, Nicholas C, et al.
Publicado: (2021)

Osteoporosis in the European Union: a compendium of country-specific reports
por: Svedbom, A., et al.
Publicado: (2013)

Congressional Scorecard
Publicado: (1994)

The Scorecard Solution
por: King, Dan
Publicado: (2015)

Correction: UK clinical guideline for the prevention and treatment of osteoporosis
por: Gregson, Celia L., et al.
Publicado: (2022)

Alignment: using the balanced scorecard to create corporate synergies
por: Kaplan, Robert S, et al.
Publicado: (2006)

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
por: Hernlund, E., et al.
Publicado: (2013)

Scoping review of balanced scorecards for use in healthcare settings: development and implementation
por: Bohm, Victoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3emnh3u01890s0h9n72bckhl9n